Evaluating SCUBE-1 as Predictive Biomarker for Hypertension-Mediated Organ Damage: A Comparative Study

Area of Science:

• Cardiovascular Research
• Biomarker Discovery
• Hypertension Studies

Background:

• Hypertension-mediated organ damage (HMOD) is a major complication affecting cardiac, retinal, and renal systems.
• Serum signal peptide, CUB domain, and EGF-like domain-containing protein 1 (SCUBE-1) is a novel biomarker associated with vascular pathology.
• Investigating SCUBE-1's role in detecting HMOD is crucial for patient outcomes.

Purpose of the Study:

• To explore the relationship between SCUBE-1 levels and HMOD in hypertensive individuals.
• To assess the diagnostic utility of SCUBE-1 for detecting HMOD in hypertension.

Main Methods:

• A cross-sectional study involving 115 participants (79 hypertensive, 36 controls).
• Hypertensive patients were categorized based on the presence or absence of HMOD.
• SCUBE-1 levels were quantified and analyzed for diagnostic accuracy.

Main Results:

• Hypertensive patients showed significantly higher SCUBE-1 levels (160.70 ng/mL) than controls (75.64 ng/mL).
• Patients with HMOD exhibited markedly elevated SCUBE-1 levels (311.27 ng/mL) compared to those without HMOD (142.53 ng/mL).
• SCUBE-1 demonstrated significant diagnostic potential for cardiac (AUC 0.722), retinal (AUC 0.761), and renal (AUC 0.707) damage.

Conclusions:

• SCUBE-1 levels are significantly elevated in hypertensive patients, especially those with HMOD.
• SCUBE-1 shows promise as a valuable biomarker for predicting organ damage in hypertension.
• Further research can validate SCUBE-1 for clinical application in HMOD assessment.